The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. (Q51754944)
Jump to navigation
Jump to search
scientific article published on 31 July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. |
scientific article published on 31 July 2017 |
Statements
1 reference
The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. (English)
1 reference
Fahrettin Haczeyni
1 reference
Hans Wang
1 reference
Vanessa Barn
1 reference
Auvro R Mridha
1 reference
Matthew M Yeh
1 reference
W Geoffrey Haigh
1 reference
George N Ioannou
1 reference
Yun-Jung Choi
1 reference
Charles A McWherter
1 reference
Narcissus C-H Teoh
1 reference
Geoffrey C Farrell
1 reference
31 July 2017
1 reference
1 reference
1
1 reference
7
1 reference
663-674
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference